NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 841.50
-12.30 (-1.44%)
Aug 31, 2026, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 150.72 billion as of August 31, 2026. Its market cap has decreased by -2.38% in one year.
Market Cap
150.72B
Enterprise Value
136.57B
Revenue
34.85B
Ranking
n/a
PE Ratio
13.17
Stock Price
841.50
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 150.72B, an increase of 35,001.30%. That is a compound annual growth rate of 23.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 150.72B | -6.82% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 321.26B |
| Piramal Pharma | 290.22B |
| Eris Lifesciences | 182.19B |
| Cohance Lifesciences | 172.12B |
| Alivus Life Sciences | 165.72B |
| Alembic Pharmaceuticals | 159.89B |
| Sudeep Pharma | 130.13B |
| Akums Drugs and Pharmaceuticals | 118.29B |